X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/medivirs-partner-vetbiolix-announces-positive-results-from-proof-of-concept-study-with-vbx-1000-previously-known-as-miv-701-302116699.html
https://www.prnewswire.com/news-releases/medivir-to-present-at-investing-in-oncology-forum-on-april-10-302111731.html
https://www.prnewswire.com/news-releases/medivir-2023-annual-report-published-302108380.html
https://www.prnewswire.com/news-releases/medivir-to-present-at-the-life-science-day-in-gothenburg-on-march-6-302078275.html
https://www.prnewswire.com/news-releases/medivir-announces-the-outcome-of-the-directed-share-issue-which-was-announced-on-22-january-2024-302045564.html
https://www.prnewswire.com/news-releases/medivir-to-present-at-the-redeye-fight-cancer-day-302042942.html
https://www.prnewswire.com/news-releases/medivir-invites-to-a-conference-call-today-on-updated-data-at-asco-gi-and-the-plans-moving-forward-for-fostrox-in-primary-liver-cancer-hcc-302041592.html
https://www.prnewswire.com/news-releases/medivir-carries-out-a-directed-share-issue-of-approx-sek-20-million-302041332.html
https://www.prnewswire.com/news-releases/fostrox--lenvima-shows-further-improved-response-rates-and-time-to-progression-in-advanced-liver-cancer-hcc-at-asco-gi-symposium-302036736.html
https://www.prnewswire.com/news-releases/medivirs-licensee-tango-therapeutics-has-dosed-the-first-patient-with-tng348-a-novel-usp1-inhibitor-in-a-phase-12-clinical-study-302026095.html
Market Place
Share 
